fbpx An update on Mmr | Page 214 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

Positive results for the EuroChar project

The Italian National Research Council (CNR) coordinates EuroChar, a European project dedicated to the development of technologies for long-term carbon sequestration and large-scale removal of greenhouse gases (GHG) from the atmosphere. EuroChar investigates carbon sequestration potentials achieved by transforming plant biomass into charcoal (or Biochar) that can be added to agricultural soils. EuroChar is a part of the Seventh Framework Programme, it started in 2011 and it was to